EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1 mouse model of Alzheimer's disease

Marina Daniela Manescu iD, Bogdan Catalin iD, Ioana Baldea iD, Valentin Octavian Mateescu iD, Gabriela Camelia Rosu iD, Ianis Kevyn Stefan Boboc iD, Anca-Maria Istrate-Ofiteru iD, Ilona Mihaela Liliac iD, Costin Teodor Streba iD, Samir Kumar-Singh iD, Daniel Pirici iD

Alzheimer's & Dementia · 2025-05 · 21 (5)

DOI: 10.1002/alz.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.05.2025. Verfasst von Marina Daniela Manescu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology, University of Medicine and Pharmacy of Craiova, Craiova, Romania. Hauptthemen laut MEDLINE: Alzheimer Disease, Aquaporin 4, Amyloid beta-Peptides, Cognition. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Deficiency in the aquaporin‐4 (AQP4) water channel has been linked to impaired amyloid beta (Aβ) clearance. However, a detailed morphopathological analysis of amyloid deposition following AQP4 therapeutic modulation remains unexplored. METHODS Two‐month‐old amyloid precursor protein presenilin 1 (APPPS1) mice were treated daily for 28 days with either the AQP4 facilitator N‐(3‐(Benzyloxy)pyridin‐2‐yl) benzene‐sulfonamide (TGN‐073) or the AQP4 inhibitor N‐(1,3,4‐thiadiazol‐2‐yl)pyridine‐3‐carboxamide dihydrochloride (TGN‐020) (both at 200 mg/kg). Controls included vehicle‐treated APPPS1 and WT C57BL/6J mice. Comprehensive histopathological, biochemical, and behavioral analyses were conducted. RESULTS Mice treated with AQP4 facilitator showed a significant reduction in total Aβ, fibrillar deposits, and soluble Aβ, while the AQP4 inhibitor caused a substantial increase in brain Aβ. AQP4‐facilitator treatment also reduced Aβ40 levels and Aβ40/Aβ42 ratio, whereas the inhibitor treatment increased both Aβ40 and Aβ42. Additionally, facilitator‐treated mice demonstrated reduced anxiety and improved memory performance. DISCUSSION These findings suggest that AQP4 modulation is a promising strategy to enhance Aβ clearance and a potential therapeutic target in Alzheimer's disease. Highlights Intramural periarterial drainage of the interstitial fluid mediated by aquaporin‐4 (AQP4) is a key element that ensures clearance of catabolites/Aβ peptide from within the brain parenchyma. Inhibition of AQP4 in an APPPS1 mouse model of AD leads to increased amyloid deposition and deficient behavior compared to untreated transgenic animals. Pharmaceutical facilitation of AQP4 in the same APPPS1 mouse model leads to a massive decrease in amyloid burden and improves the behavioral performance of the animals compared to untreated control APPPS1 mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAquaporin 4Amyloid beta-PeptidesCognitionAnimalsMiceDisease Models, AnimalAmyloid beta-Protein PrecursorMice, TransgenicMice, Inbred C57BLPresenilin-1ThiadiazolesBrain

Stichwörter der Autor:innen

APPPS1 mouse modelAlzheimer's diseaseamyloid plaquesaquaporin‐4intramural periarterial drainage

Substanzen

Aquaporin 4Amyloid beta-PeptidesAmyloid beta-Protein PrecursorPresenilin-1Thiadiazoles

Autor:innen und Institutionen

  • Department of Histology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  • Department of Physiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  • Department of Physiology, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Pulmonology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  • Laboratory of Cell Biology and Histology, Molecular Pathology Group, Faculty of Medical and Health Sciences, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Marina Daniela Manescu, Bogdan Catalin, Ioana Baldea, Valentin Octavian Mateescu, Gabriela Camelia Rosu, Ianis Kevyn Stefan Boboc, Anca-Maria Istrate-Ofiteru, Ilona Mihaela Liliac, Costin Teodor Streba, Samir Kumar-Singh, Daniel Pirici

Förderung

  • University of Medicine and Pharmacy of Craiova

Zitieren

APA

Manescu, M. D., Catalin, B., Baldea, I., Mateescu, V. O., Rosu, G. C., Boboc, I. K. S., Istrate-Ofiteru, A. M., Liliac, I. M., Streba, C. T., Kumar-Singh, S., & Pirici, D. (2025). Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1 mouse model of Alzheimer's disease. Alzheimer's & Dementia, 21(5). https://doi.org/10.1002/alz.70164

Vancouver

Manescu MD, Catalin B, Baldea I, Mateescu VO, Rosu GC, Boboc IKS, et al. Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1 mouse model of Alzheimer's disease. Alzheimer's & Dementia. 2025;21(5). doi:10.1002/alz.70164

BibTeX
@article{Manescu2025,
  author = {Manescu, Marina Daniela and Catalin, Bogdan and Baldea, Ioana and Mateescu, Valentin Octavian and Rosu, Gabriela Camelia and Boboc, Ianis Kevyn Stefan and Istrate-Ofiteru, Anca-Maria and Liliac, Ilona Mihaela and Streba, Costin Teodor and Kumar-Singh, Samir and Pirici, Daniel},
  title = {Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1 mouse model of Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {5},
  doi = {10.1002/alz.70164}
}
Kostenlos starten →